Patentability and Intellectual Property Issues Related to Chitosan-Based Biopharmaceutical Products
General Material Designation
[Book]
First Statement of Responsibility
Mafalda Videira Affiliation: Nanomedicine and Drug Delivery Systems Group, iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
GENERAL NOTES
Text of Note
Number of Tables: 3; Number of References: 150
SUMMARY OR ABSTRACT
Text of Note
This chapter contains sections titled: Introduction Setting the Scene: The Role of Chitosan as a Pharmaceutical Excipient Addressing the Drivers for Scientific Progress on Chitosan: Innovation and Inventability Conclusions and Future Perspectives References
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RM666
.
C39
Book number
M343
9999
PERSONAL NAME - PRIMARY RESPONSIBILITY
Mafalda Videira Affiliation: Nanomedicine and Drug Delivery Systems Group, iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Mafalda Videira Affiliation: Nanomedicine and Drug Delivery Systems Group, iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Rogério Gaspar Affiliation: Nanomedicine and Drug Delivery Systems Group, iMed.UL- Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal